Integrated proteomic profiling identifies amino acids selectively cytotoxic to pancreatic cancer cells.

ABSTRACT: Pancreatic adenocarcinoma (PDAC) is one of the most deadly cancers, characterized by extremely limited therapeutic options and a poor prognosis, as it is often diagnosed during late disease stages. Innovative and selective treatments are urgently needed, since current therapies have limited efficacy and significant side effects. Through proteomics analysis of extracellular vesicles, we discovered an imbalanced distribution of amino acids secreted by PDAC tumor cells. Our findings revealed that PDAC cells preferentially excrete proteins with certain preferential amino acids, including isoleucine and histidine, via extracellular vesicles. These amino acids are associated with disease progression and can be targeted to elicit selective toxicity to PDAC tumor cells. Both in vitro and

SUBMITTER: Akinlalu A 

PROVIDER: S-EPMC11063643 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature